Records 1 - 30
| A large-scale prospective concordance study of plasma- and tissue-based next-generation targeted sequencing for advanced non-small cell lung cancer (LC-SCRUM-Liquid).
Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Oct .
Sugimoto Akira, Matsumoto Shingo, Udagawa Hibiki, Itotani Ryo, Usui Yuko, Umemura Shigeki, Nishino Kazumi, Nakachi Ichiro, Kuyama Shoichi, Daga Haruko, Hara Satoshi, Miyamoto Shingo, Kato Terufumi, Sakakibara-Konishi Jun, Tabata Eriko, Nakagawa Taku, Kawaguchi Tomoya, Sakai Tetsuya, Shibata Yuji, Izumi Hiroki, Nosaki Kaname, Zenke Yoshitaka, Yoh Kiyotaka, Goto Koic
| Age does matter in adolescents and young adults vs. older adults with lung adenocarcinoma: A retrospective analysis comparing clinical characteristics and outcomes in response to systematic treatments.
Oncology letters 2022 Oct 24 (4): 362.
Zhou Lin, Li Huiwu, Yang Shuh
| Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis.
European journal of radiology 2022 Oct 155 110499.
Li Ye, Lv Xinna, Wang Bing, Xu Zexuan, Wang Yichuan, Gao Shan, Hou Dail
| ERBB2 exon 20 insertions are rare in Brazilian non-small cell lung cancer.
Thoracic cancer 2022 Oct .
de Oliveira Cavagna Rodrigo, Zaniolo Beatriz Garbe, de Paula Flávia Escremim, Berardinelli Gustavo Noriz, Santana Iara, da Silva Eduardo Caetano Albino, Dias Josiane Mourão, Jacinto Alexandre Arthur, da Nóbrega Oliveira Rachid Eduardo Noleto, de Marchi Pedro, Leal Letícia Ferro, Reis Rui Manu
| First-in-human phase I study of TQ-B3139 (CT-711) in advanced non-small cell lung cancer patients with ALK and ROS1 rearrangements.
European journal of cancer (Oxford, England : 1990) 2022 Sep 173 238-249.
Ma Yuxiang, Zhao Hongyun, Xue Jinhui, Liu Li, Yang Nong, Zhang Yang, Yang Haiyan, Hong Shaodong, Xiong Yi, Zhang Zhonghan, Zeng Liang, Pan Hui, Zhou Chunhua, Zhang Yongchang, Wang Xunqiang, Han Xi, Wan Xiaojing, Shao Yang, Liu Jingwen, Yang Yunpeng, Huang Yan, Zhao Yuanyuan, Fang Wenfeng, Li Su, Zhang
| Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis.
Thoracic cancer 2022 Sep 13 (18): 2574-2583.
Nie Naifu, Zhou Haodong, Zhang Kejun, Liu Lan, Luo Nuo, Wang Renyuan, Li Xin, Zhu Mengxiao, Hu Chen, Wang Yubo, Liu Zhulin, Li Li, He Yo
| Results from the IMpower132 China cohort: Atezolizumab plus platinum-based chemotherapy in advanced non-small cell lung cancer.
Cancer medicine 2022 Sep .
Lu Shun, Fang Jian, Wang Ziping, Fan Yun, Liu Yunpeng, He Jianxing, Zhou Jianying, Hu Jie, Xia Jinjing, Liu Wenxin, Shi Jane, Yi Jing, Cao Lej
| Advances in the treatment of postoperative recurrence of non-small cell lung cancer and their impact on survival in Asian patients.
The Journal of thoracic and cardiovascular surgery 2022 Aug .
Hashimoto Kohei, Ariyasu Ryo, Ichinose Junji, Matsuura Yosuke, Nakao Masayuki, Amino Yoshiaki, Uchibori Ken, Kitazono Satoru, Yanagitani Noriko, Okumura Sakae, Nishio Makoto, Mun Mingy
| Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program.
Seminars in oncology 2022 Jul .
Jalal Shadia I, Guo Aixia, Ahmed Sara, Kelley Michael
| CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma.
Medicine 2022 Jul 101 (30): e29796.
Zhang Sen, Li Na, Yang Yonghua, Li Yan, Lin Chenshi, Fu Guoquan, Cai J
| Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trial.
Lung cancer (Amsterdam, Netherlands) 2022 Jul 169 67-76.
Soo Ross A, Huat Tan Eng, Hayashi Hidetoshi, Seto Takashi, Lin Chia-Chi, Ignatius Ou Sai-Hong, Kim Dong-Wan, Liu Geoffrey, Abbattista Antonello, Martini Jean-François, Hooi Wong Chew, Toffalorio Francesca, Solomon Benjamin
| A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib.
BMC medical genomics 2022 Jun 15 (1): 141.
Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X
| Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab.
JAMA network open 2022 Jun 5 (6): e2215589.
Liu Yufei, Zhang Zhe, Rinsurongkawong Waree, Gay Carl M, Le Xiuning, Ning Matthew S, Lewis Jeff, Rinsurongkawong Vadeerat, Lee J Jack, Roth Jack, Swisher Stephen, Gandhi Saumil, Lee Percy P, Gibbons Don L, Vaporciyan Ara A, Heymach John V, Zhang Jianjun, Lin Steven
| Computed tomography-guided lung biopsy for molecular tests: a meta-analysis.
Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery 2022 Jun 19 (2): 96-101.
Zhang Jian-Hua, Xia Feng-Fei, Yang Xiao-Shan, Li
| Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial.
Cancer 2022 Jun .
Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam
| An individual nomogram can reliably predict tumor spread through air spaces in non-small-cell lung cancer.
BMC pulmonary medicine 2022 May 22 (1): 209.
Wang Shuai, Shou Huankai, Wen Haoyu, Wang Xingxing, Wang Haixing, Lu Chunlai, Gu Jie, Xu Fengkai, Zhu Qiaoliang, Wang Lin, Ge
| Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases.
The oncologist 2022 May .
Huang Richard S P, Harries Lukas, Decker Brennan, Hiemenz Matthew C, Murugesan Karthikeyan, Creeden James, Tolba Khaled, Stabile Laura P, Ramkissoon Shakti H, Burns Timothy F, Ross Jeffrey
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
BMC cancer 2022 May 22 (1): 580.
Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic
| Genomic features of Chinese small cell lung cancer.
BMC medical genomics 2022 May 15 (1): 117.
Liu Jun, Zhao Zhuxiang, Wei Shuquan, Li Binkai, Zhao Ziw
| First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.
International journal of clinical oncology 2022 Feb .
John Thomas, Sakai Hiroshi, Ikeda Satoshi, Cheng Ying, Kasahara Kazuo, Sato Yuki, Nakahara Yoshiro, Takeda Masayuki, Kaneda Hiroyasu, Zhang Helong, Maemondo Makoto, Minato Koichi, Hisada Takeshi, Misumi Yuki, Satouchi Miyako, Hotta Katsuyuki, Li Ang, Oukessou Abderrahim, Lu Sh
| Impact of genetic status on the survival outcomes of patients with clinical stage I non-small cell lung cancer with a radiological pure-solid appearance.
Lung cancer (Amsterdam, Netherlands) 2022 Feb 166 63-69.
Sun Ke, Li Meiling, Shang Mingdong, Su Xiaolian, Zhao Jiabi, Wang Bin, Wu Chunyan, Zhang Lei, Yang Shan, Sun Xiw
| ALK fusion variant 3a/b, concomitant mutations, and high PD-L1 expression were associated with unfavorable clinical response to second-generation ALK TKIs in patients with advanced ALK-rearranged non-small cell lung cancer (GASTO 1061).
Lung cancer (Amsterdam, Netherlands) 2022 Jan 165 54-62.
Li Meichen, Hou Xue, Chen Jing, Zhang Baishen, Wang Na, Han Hongyu, Chen Lik
| Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma.
Pathology, research and practice 2022 Jan 231 153761.
Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu
| A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer.
Frontiers in medicine 2022 9 808378.
Peng Jie, Xiao Lushan, Zou Dan, Han Lij
| Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer.
PloS one 2022 17 (10): e0276161.
Chow Yock Ping, Zainul Abidin Norziha, Kow Ken Siong, Tho Lye Mun, Wong Chieh L
| Common genetic driver mutation in NSCLC and their association with thromboembolic events: A retrospective study.
Lung cancer (Amsterdam, Netherlands) 2022 10 172 29-34.
Lin Miaozhen, Lu Yujuan, Yu Qiwen, Chen Zebin, Peng Jiayu, Cai Xiu
| Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50.
Frontiers in oncology 2022 12 980765.
Attili Ilaria, Valenza Carmine, Santoro Celeste, Antonarelli Gabriele, Trillo Aliaga Pamela, Del Signore Ester, Catania Chiara, Spitaleri Gianluca, Passaro Antonio, de Marinis Filip
| Genomic landscape of lung adenocarcinomas in different races.
Frontiers in oncology 2022 12 946625.
Shi Huashan, Seegobin Karan, Heng Fei, Zhou Kexun, Chen Ruqin, Qin Hong, Manochakian Rami, Zhao Yujie, Lou Yany
| Genomic landscape of lung cancer in the young.
Frontiers in oncology 2022 12 910117.
Ruiz Rossana, Galvez-Nino Marco, Roque Katia, Montes Jaime, Nuñez Maria, Raez Luis, Sánchez-Gambetta Sergio, Jaúregui Sandra, Viale Sandra, Smith Edward S, Pinto Joseph A, Mas Lu
| A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution.
Lung India : official organ of Indian Chest Society 0 39 (4): 315-318.
Roy Mohana, Bal Amanjit, Gupta Nalini, Prasad Kuruswamy T, Wakelee Heather A, Singh Navne